Skip to main content

Hawaii Health Department’s enforcement of hemp retailers is helping compliance

HI: DOH ENFORCEMENT OF HEMP RETAILERS CONTROVERSY

Click here for updates on this story

    HONOLULU (KITV) — It’s been two weeks since the Department of Health (DOH) began enforcement of Hawaii’s hemp retailers. Some critics of the new rules said it’s driving them out of business.

“Millions in damage has already been done,” said hemp retailer Lance Alyas.

This is one of dozens of hemp retailers here in the islands now at risk of being shut down under new rules being enforced by the Department of Health.

“Twenty to 30 businesses closed down and a majority of them have stopped selling these products completely,” he said.

The owner of Oahu Dispensary and Provisions said hemp retailers are living in fear. The DOH began enforcing new laws in July, requiring businesses to register with DOH in order to sell hemp products and ensure operators are complying with limits on THC — the psychoactive compound in pakalolo.

“That’s a crackdown. That’s enforcement in and of itself,” Alyas said. “It’s intimidating when the Department of Health comes to your business and says you can’t sell this, you can’t sell that, or else we’ll close you down or we’ll criminally enforce on you.”

For some businesses like Alyas’, that’s about 90% of inventory.

He’s one of almost 60 licensed retailers selling manufactured hemp products, but is suing the state to reverse the new rules.

“We face revenue loss. We’ve had employees leave because they don’t want the uncertainty,” he said. “When we closed down we had countless people — cancer patients included — crying to us because they don’t know where to get their medicine.”

Medical marijuana dispensary Aloha Green Apothecary said previously the state had no real regulations and relied on the federal rules for selling hemp products.

“What legislators didn’t know was that hemp cannabinoids could be manipulated to create higher THC products and these higher THC products can be euphoric and cause intoxication,” said Ty Cheng, president of Aloha Green Apothecary. “The issue that many hemp retailers face right now is that they’re uncomfortable with the level of regulation that they’re being subjected to.”

The DOH has visited almost 30 registered businesses and said so far compliance has been good. But there are still other businesses likely not following the rules.

“The THC limits they’ve been in place for a long time okay and some of the products like the vapes and the smokeables you were never allowed to sell in Hawaii,” said Andrew Goff, DOH Office of Medical Cannabis Control and Regulation program manager. “Our goal is not to crack down on people selling hemp. Our goal is to make sure people are compliant. So we’re starting with education and with warnings, and to make sure that everyone knows because it is a confusing area.”

DOH is urging consumers and businesses to read the labels on products that you are buying or selling.

Please note: This story was provided to CNN Wire by an affiliate and does not contain original CNN reporting. This content carries a strict local market embargo. If you share the same market as the contributor of this article, you may not use it on any platform.

Lindsay Clancy murder trial resumes with testimony from psychiatric nurse who examined her

(CNN) — A psychiatric nurse practitioner who examined Lindsay Clancy months before she killed her three children took the stand Tuesday in the third week of the Massachusetts mother’s murder trial.Rebecca Jollotta, a psychiatric nurse practitioner with South Shore Hospital’s perinatal behavioral health program, testified she had a telehealth visit with Clancy in November 2022. Clancy appeared anxious and was struggling to get a full night sleep. Still, she had no signs of mania or psychosis, and her thought process was “linear” and “goal-directed,” Jollotta testified.The testimony comes three weeks into Clancy’s trial on three counts of murder in the killings of her children Cora, 5; Dawson, 3; and Callan, 8 months. The trial has featured testimony about the lead-up to the killings and Clancy’s struggles with post-partum anxiety, depression and insomnia — and stoked a nationwide conversation about the issues.Prosecutors have argued Clancy “acted intentionally, rationally and swiftly” when she fatally strangled her three children and attempted suicide at their Duxbury home on January 24, 2023.Her defense attorneys have argued what’s known as the “insanity defense,” saying she is not criminally responsible because she was in the midst of a psychotic episode stemming from postpartum mental illness.Her family, friends and mental health professionals have said Clancy did not show any signs of psychosis before or after the killings and did not believe she was a danger to herself or her children. Yet those who knew her unanimously said she was a caring mother whose mental health was deteriorating. Clancy told one friend in January 2023 that a medication caused her to have “some dark thoughts,” the friend testified.Tuesday marks Clancy’s 36th birthday.Testimony began two weeks ago with opening statements and an emotional witness account from her husband, Patrick Clancy. Last week’s testimony focused on her mental health status before and after the killings, her physical injuries from her suicide attempt, and her friends’ and family’s concerns.The trial is expected to last six to eight weeks. Clancy faces life in prison if convicted of murder. She is being held at the public Tewksbury Hospital in Massachusetts, which specializes in treating those with mental illness.Defense sharply questions mental health expertsOn Monday, Clancy’s defense attorney Kevin Reddington sharply questioned Dr. Jennifer Tufts, Clancy’s primary psychiatrist, about her treatment plan and her expertise.Tufts saw Clancy 14 times between September 2022 to January 2023, repeatedly adjusting her prescriptions as Clancy grappled with anxiety, depression and insomnia. She also provided counseling support.“I listened to her, listened to her concerns, provided support, tried to provide her with hope that things would improve,” Tufts said.Reddington challenged Tufts on her qualifications and experience, her use of telemedicine, her many prescriptions and her notes. He repeatedly cut off her answers with follow-up questions, leading to objections from the prosecution and admonishments from the judge.“If I ask you a question, respectfully, can you just not go on and ramble? Answer yes or no, that’s all,” Reddington said.“It’s sometimes impossible to do that,” Tufts responded.Tufts finished her residency in August 2022 and saw Clancy for the first time a month later. She testified she had treated at least 50 people with postpartum issues during her residency.Tufts’ and Clancy’s 14 visits were all conducted via telemedicine, and this trial is the first time they have been in the same room together, Tufts testified. Reddington challenged her use of telemedicine and noted she couldn’t even give Clancy a hug over the computer.“I couldn’t give her a hug, but that’s not actually something psychiatrists typically do with patients,” Tufts said.Tufts said she almost exclusively relied on Clancy’s own statements in evaluating her mental health. She did not speak to Clancy’s parents and only spoke to her husband at one session in December 2022.On Monday afternoon, Julie Paul, a psychiatric nurse practitioner, testified that Clancy in November 2022 had anxiety, felt overwhelmed and had racing thoughts, conditions that are “very typical” for postpartum patients. Paul prescribed Clancy Prozac and advised her that the medication takes some time to see benefits, but within days Clancy reported she wanted to switch to a different medication.It was part of a pattern for Clancy, who took about a dozen different medications between late 2022 and January 2023, according to testimony in the trial.“I keep reaching out to different people and not sticking with the plan,” Clancy said, according to Tufts.This is a developing story and will be updated.The-CNN-Wire™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
Read Next Story